Corient Private Wealth
PRCT icon

Corient Private Wealth’s Procept Biorobotics PRCT Stock Holding History

Corient Private Wealth’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Buy
+57,119
New +$1.61M ﹤0.01% 1445
2025
Q4 		– Sell
-6,251
Closed -$223K – 2811
2025
Q3 		$223K Buy
6,251
+321
+5% +$14.7K ﹤0.01% 2298
2025
Q2 		$342K Sell
5,930
-38
-0.6% -$2.15K ﹤0.01% 1922
2025
Q1 		$348K Buy
5,968
+137
+2% +$9.35K ﹤0.01% 1779
2024
Q4 		$470K Buy
5,831
+109
+2% +$9.31K ﹤0.01% 1659
2024
Q3 		$458K Buy
5,722
+372
+7% +$26.4K ﹤0.01% 1788
2024
Q2 		$327K Sell
5,350
-475
-8% -$28.3K ﹤0.01% 1855
2024
Q1 		$288K Buy
+5,825
New +$277K ﹤0.01% 1916

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Corient Private Wealth's PRCT Position: Q1 2026 in Review

Corient Private Wealth opened a new position in Procept Biorobotics (PRCT) in Q1 2026: 57,119 shares worth $1.43M. The stake represents ﹤0.01% of the portfolio and ranks #1445 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in PRCT as recently as Q3 2025.

Corient Private Wealth first reported a position in PRCT in Q1 2024 and has held it in 8 quarters since. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Corient Private Wealth held 57,119 shares of Procept Biorobotics worth $1.43M as of Q1 2026.
  • Procept Biorobotics was a new Corient Private Wealth position in Q1 2026.
  • Procept Biorobotics made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1445 holding.
  • Corient Private Wealth first reported a position in Procept Biorobotics in Q1 2024 and has held it in 8 quarters since.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.